Drug Type Recombinant coagulation factor |
Synonyms Activated recombinant human factor VII, Eptacog Alfa (Activated) (Genetical Recombination), Eptacog alfa (Novo Nordisk) + [21] |
Target |
Mechanism F10 stimulants(Coagulation factor X stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (23 Feb 1996), |
RegulationOrphan Drug (US), Orphan Drug (JP) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Eptacog alfa(Novo Nordisk A/S) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Factor VII Deficiency | JP | 10 Mar 2000 | |
Hemophilia A | JP | 10 Mar 2000 | |
Hemophilia B | JP | 10 Mar 2000 | |
Acquired hemophilia | US | 25 Mar 1999 | |
Hemophilia | EU | 23 Feb 1996 | |
Hemophilia | IS | 23 Feb 1996 | |
Hemophilia | LI | 23 Feb 1996 | |
Hemophilia | NO | 23 Feb 1996 | |
Thrombasthenia | EU | 23 Feb 1996 | |
Thrombasthenia | IS | 23 Feb 1996 | |
Thrombasthenia | LI | 23 Feb 1996 | |
Thrombasthenia | NO | 23 Feb 1996 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Postpartum Hemorrhage | NDA/BLA | EU | 23 Apr 2022 | |
Hemorrhage | Phase 3 | US | 01 Oct 2005 | |
Hemorrhage | Phase 3 | BR | 01 Oct 2005 | |
Hemorrhage | Phase 3 | CZ | 01 Oct 2005 | |
Hemorrhage | Phase 3 | FR | 01 Oct 2005 | |
Hemorrhage | Phase 3 | DE | 01 Oct 2005 | |
Hemorrhage | Phase 3 | GR | 01 Oct 2005 | |
Hemorrhage | Phase 3 | HK | 01 Oct 2005 | |
Hemorrhage | Phase 3 | HU | 01 Oct 2005 | |
Hemorrhage | Phase 3 | IT | 01 Oct 2005 |
Not Applicable | - | kmxzyrldeo(ttqbdgkyas) = gqwioyiprv bgrfecyccd (ddpfraajdw ) View more | - | 12 Jul 2020 | |||
Not Applicable | - | - | rhordseskz(cziipxypkr) = wrplfobjca mstmewmllz (yuwcwalrxo ) | - | 21 May 2015 | ||
Phase 3 | 72 | (Vatreptacog Alfa 80 µg/kg) | ywaelcuvgi(hwlokumeln) = zcgkfzygax fmsbskvsjg (fjftquonjx, vthqaazejx - bxuqdgdrak) View more | - | 06 Dec 2013 | ||
(rFVIIa 90 µg/kg) | ywaelcuvgi(hwlokumeln) = ceizzathmz fmsbskvsjg (fjftquonjx, hrnxzpthag - tqtooglirz) View more | ||||||
Not Applicable | - | - | rbyesltdpk(qpnaklexjb) = fmaupirwqo kwebvcgnun (mrpudovzfa ) View more | - | 01 Aug 2013 | ||
Plasma-derived factor VII | rbyesltdpk(qpnaklexjb) = cvveszbcdk kwebvcgnun (mrpudovzfa ) View more | ||||||
Not Applicable | - | plfhnsmnof(almxexyzzu) = zipegpnnna iviurdadpq (ksfkzxxjqr ) | - | 20 May 2012 | |||
Not Applicable | - | Recombinant Activated Factor VII (rFVIIa) | oumjpfczpm(sbnlbalqlq) = sosoekwati fiviqomcgf (upqufykopn ) | - | 01 Jul 2005 | ||
Recombinant Activated Factor VII | oumjpfczpm(sbnlbalqlq) = fczsugqpna fiviqomcgf (upqufykopn ) | ||||||
Not Applicable | 7 | lphjzwzydi(gvwttkofgj) = vkcamoecxe qvelbqtdou (egqhilqnej ) View more | - | 01 Sep 2001 |